Video Experimental Relacionado
Updated: Sep 10, 2025
06:08
Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
1.9K
La formononetina mejora el asma alérgica mediante la inhibición de la JUN y la supresión de las respuestas inmunes de
Jian Liu1, Yanyan Li2, Meng Liu1
1Respiratory Department, Beijing Traditional Chinese Medicine Hospital, Capital Medical University, Beijing 100010, China.
Molecular immunology
|August 20, 2025
Resumen
Formononetin (FM) trata eficazmente el asma alérgica reduciendo la inflamación de las vías respiratorias y el moco. Se dirige a las respuestas inmunitarias de tipo II y a la migración celular inhibiendo el gen JUN.
Área de la Ciencia:
- Inmunología
- Farmacología
- Medicina de las vías respiratorias
Sus antecedentes:
- El asma alérgica (AS) es una enfermedad respiratoria crónica caracterizada por la inflamación de las vías respiratorias y la hipersensibilidad.
- Las células linfoides innatas de tipo II (ILC2) juegan un papel crítico en la patogénesis del asma alérgica.
- La formononetina (FM), un flavonoide natural, tiene propiedades antiinflamatorias.
Objetivo del estudio:
- Investigar el potencial terapéutico de la formononetina (FM) en un modelo murino de asma alérgica (AS).
- Para aclarar los mecanismos subyacentes de la acción de FM, centrándose en ILC2s y el gen JUN.
Principales métodos:
- Se estableció un modelo murino de AS inducido por ovalbúmina (OVA) y se trató con FM.
- Evaluación de la inflamación de las vías respiratorias, la secreción de moco y la activación/migración de ILC2 mediante histología, ELISA y citometría de flujo.
- Investigación del papel del gen JUN utilizando análisis moleculares y un agonista de JUN (15(S) -HpETE); ensayos in vitro evaluaron los efectos de la FM en las ILC2.
Principales resultados:
- El tratamiento de FM alivió significativamente la inflamación de las vías respiratorias, redujo la hipersecreción de moco y redujo los niveles séricos de IgE en ratones con EA.
- La FM disminuyó la abundancia, activación y migración del eje pulmonar-intestinal de las ILC2, suprimiendo la expresión de citoquinas y factores de transcripción relacionados.
- Los estudios in vitro confirmaron la supresión de la proliferación y activación de ILC2 por FM, con efectos revertidos por 15S-HpETE, lo que indica un mecanismo dependiente de JUN.
Conclusiones:
- Formononetin (FM) mejora el asma alérgica inhibiendo las respuestas inmunitarias de tipo II y la migración de ILC2 a través de la orientación del gen JUN.
- FM demuestra potencial como agente terapéutico para el asma, ofreciendo un nuevo enfoque mediante la modulación de la inflamación mediada por ILC2.
Palabras clave:
Inflamación de las vías respiratoriasAsma alérgicaFormononetina también se utiliza para el tratamiento deILC2 (en inglés)JUNIOMás Videos Relacionados
08:25An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
Published on: April 27, 2021
2.5K
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
7.7K
Videos de Conceptos Relacionados
01:19Antiasthma Drugs: Leukotriene Modifiers
463
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
463
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
453
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
453
01:20Asthma: Pathogenesis and Management
581
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
581
01:17Drugs Used in Lower Respiratory Disorders: Overview
578
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
578
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
452
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
452